Allison Schneider, MPH, provides a detailed update regarding pharmacies’ impact within Medicare price negotiations and the legislation further impacting businesses.
|Videos|May 4, 2022
Stories of Success: Dokimos' Pharmacy
Author(s)Lauren Biscaldi, MS
Jacqueline Paye, PharmD, shares how her pharmacy continued to serve its rural community during the pandemic.
Advertisement
As a part of American Associated Pharmacies' Stories of Success series,Jacqueline Paye, PharmD, head pharmacist at Dokimos' Pharmacy in Nevada City, California, tells the story of how her pharmacy continued to serve its rural community during the pandemic.
Advertisement
Related to this article
Allison Schneider, MPH, provides expertise on how IRA drug price negotiations have impacted pharmacies in 2026 and what’s to come in the years ahead.
Researchers say this net loss is unlikely to reverse without state and federal policy changes, including PBM reform.
Among a collection of patients across 15 pharmacies, researchers assessed acceptability and satisfaction with pharmacist-led clinical services.
Zaid Fadul, MD, FS, FAAFP, joins for part 2 to discuss what greater adoption of AI across health care ecosystems might mean for pharmacists, patients, and more.
For pharmacies competing with CVS and relying on Caremark to serve patients, the prospect of those businesses operating under separate ownership is significant.
The inquiry puts audit practices, including how pharmacies are selected for audit, proportionality, and pharmacy advocacy in focus.
The finalized rule is another step in the right direction for pharmacies calling for reform due to underwater reimbursement and other PBM pressures.
Advertisement
Advertisement
Trending on Drug Topics
1
US Lost Over 3000 Pharmacies From 2022 to 2024, Mostly Chains
2
CVS Plans to Split Off Its Retail Pharmacies, Keeping Specialty Operations
3
How Pharmacist-Led ART Protocol Improves HIV Medication Outcomes
4
Measles Cases Near 5000 in 2026 as Flu Season Starts Earlier Than Usual
5